Human (α2→6) and Avian (α2→3) Sialylated Receptors of Influenza A Virus Show Distinct Conformations and Dynamics in Solution
Name
Sasisekharan_Human.pdf
Size
1.85 MB
Format
Adobe PDF
Checksum (MD5)
1c7788c1bd95ce534b6d039efea82b86
Author(s) • • • • • • • • •
Sassaki, Guilherme L.
Elli, Stefano
Rudd, Timothy R.
Macchi, Eleonora
Yates, Edwin A.
Naggi, Annamaria
Raman, Rahul
Torri, Giangiacomo
Guerrini, Marco
Shriver, Zachary H.
Date Issued
September 2013
Journal
Biochemistry
Publisher
American Chemical Society (ACS)
Citation
Sassaki, Guilherme L., Stefano Elli, Timothy R. Rudd, Eleonora Macchi, Edwin A. Yates, Annamaria Naggi, Zachary Shriver, et al. “Human (α2→6) and Avian (α2→3) Sialylated Receptors of Influenza A Virus Show Distinct Conformations and Dynamics in Solution.” Biochemistry 52, no. 41 (October 15, 2013): 7217–7230.
Version
Author's final manuscript
Abstract
Differential interactions between influenza A virus protein hemagglutinin (HA) and α2→3 (avian) or α2→6 (human) sialylated glycan receptors play an important role in governing host specificity and adaptation of the virus. Previous analysis of HA–glycan interactions with trisaccharides showed that, in addition to the terminal sialic acid linkage, the conformation and topology of the glycans, while they are bound to HA, are key factors in regulating these interactions. Here, the solution conformation and dynamics of two representative avian and human glycan pentasaccharide receptors [LSTa, Neu5Ac-α(2→3)-Gal-β(1→3)-GlcNAc-β(1→3)-Gal-β(1→4)-Glc; LSTc, (Neu5Ac-α(2→6)-Gal-β(1→4)-GlcNAc-β(1→3)-Gal-β(1→4)-Glc] have been explored using nuclear magnetic resonance and molecular dynamics simulation. Analyses demonstrate that, in solution, human and avian receptors sample distinct conformations, topologies, and dynamics. These unique features of avian and human receptors in solution could represent distinct molecular characteristics for recognition by HA, thereby providing the HA–glycan interaction specificity in influenza.
MIT Department
Harvard University--MIT Division of Health Sciences and Technology
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. School of Engineering
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/bi400677n